Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-21-002861
Filing Date
2021-02-23
Accepted
2021-02-23 17:09:47
Documents
76
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cort-20201231.htm   iXBRL 10-K 1847569
2 EX-4.2 cort202010-kex42.htm EX-4.2 25662
3 EX-23.1 cort202010-kex231.htm EX-23.1 3823
4 EX-31.1 cort202010-kex311.htm EX-31.1 9570
5 EX-31.2 cort202010-kex312.htm EX-31.2 9523
6 EX-32.1 cort202010-kex321.htm EX-32.1 5338
7 EX-32.2 cort202010-kex322.htm EX-32.2 5317
13 cort-20201231_g1.jpg GRAPHIC 110116
  Complete submission text file 0001628280-21-002861.txt   7773483

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20201231.xsd EX-101.SCH 46328
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20201231_cal.xml EX-101.CAL 100382
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20201231_def.xml EX-101.DEF 168494
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20201231_lab.xml EX-101.LAB 617827
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20201231_pre.xml EX-101.PRE 372934
14 EXTRACTED XBRL INSTANCE DOCUMENT cort-20201231_htm.xml XML 1258218
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 21666691
SIC: 2834 Pharmaceutical Preparations